Dr. Reem Ali is a post-doctoral fellow at Hamad bin Khalifa University. She received her PhD in targeting the base excision repair pathway in breast and ovarian cancers from the University of Nottingham in 2019. She has published key translational studies on PARP inhibitor-induced DNA damage. After joining the Wellcome Centre for Human Genetics, University of Oxford, she expanded her research on the mechanics of PARP inhibitors in endometrial cancers resistant to chemotherapy. She joined Prof Ramotar's Lab at Hamad Bin Khalifa University in 2021 to continue tackling DNA damage in cancer therapies.